Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000462044 | SCV000550052 | uncertain significance | Gastrointestinal stromal tumor | 2024-11-27 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 451 of the KIT protein (p.Ser451Pro). This variant is present in population databases (rs145183977, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with KIT-related conditions. ClinVar contains an entry for this variant (Variation ID: 409718). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV001011082 | SCV001171363 | likely benign | Hereditary cancer-predisposing syndrome | 2024-04-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001011082 | SCV002536385 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-03-18 | criteria provided, single submitter | curation | |
Baylor Genetics | RCV000462044 | SCV004198081 | uncertain significance | Gastrointestinal stromal tumor | 2024-03-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004591320 | SCV005078776 | uncertain significance | not provided | 2023-10-05 | criteria provided, single submitter | clinical testing | Has been reported in a patient with melanoma, colorectal cancer, and systemic mastocytosis (Pritchard et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29641532) |
Prevention |
RCV003409631 | SCV004113372 | uncertain significance | KIT-related disorder | 2024-06-28 | no assertion criteria provided | clinical testing | The KIT c.1351T>C variant is predicted to result in the amino acid substitution p.Ser451Pro. This variant has been reported in a cohort study of individuals with cutaneous melanoma and at least two independent additional primary cancers (Supplemental Data, Pritchard et al. 2018. PubMed ID: 29641532). This variant is reported in 0.0047% of alleles in individuals of European (Non-Finnish) descent in gnomAD and interpreted as uncertain in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/409718/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |